Explore how inClude, a novel prediction model augmented with further, advanced data science capabilities by Volv Global, revolutionizes drug development in difficult to diagnose, and often rare diseases. Introduce tangible patient-centricity to your trial designs as inClude characterises patients using real world evidence in a new way, including the previously undiagnosed ones.